Skip to content

A verification study of effective on anti-aging: A open trial

A verification study of effective on anti-aging: A open trial - A verification study of effective on anti-aging

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000025400
Enrollment
10
Registered
2016-12-26
Start date
2016-12-27
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Duration: 8 weeks Test materials: HGH crystal MD Dose: 1 pack, three times a day Administration: Take 1 pack in mouth for 40 seconds and swallow it before each meal *If you forget ingestion HGH c

Sponsors

ORTHOMEDICO Inc.
Lead Sponsor
Seishin-kai Medical Association Inc, Takara Medical Clinic
Collaborator

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Healthy Japanese women 2. BMI level is more than 25 kg/m2 3. Those who feel fatigue, look older, and need to prevent aging

Exclusion criteria

Exclusion criteria: 1. At least one previous medical history of malignant tumor, heart failure or myocardial infarction 2. Currently under the treatment for either cardiac arrhythmia, hepatic disorder, renal disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension or other chronic diseases 3. Those who use or take "Foods for Specified Health Uses" and "Foods with Functional Claims" in daily 4. Currently taking medicines and/or herbal medicines 5. Those who are allergic to medicines and/or the test food related products 6. Those who had nip and tuck such as breast implants 7. Those who are pregnant, breast-feeding, and plan to become a pregnant 8. Those who had participated another clinical test for three months when you signed the informed consent form for this trial 9. Others considered as inappropriate for the study by the physician

Design outcomes

Primary

MeasureTime frame
1. Blood test The concentration of serum IGF-1

Secondary

MeasureTime frame
1. Blood test The concentration of serum DHEA-S 2. CT scan Take CT scan images of the abdomen and an upper arm 3. Physical examination Weight, BMI, body fat percentage, abdominal circumference, and bust, hips, and waist measurement 4. Degree of glycation Measure AGEs at a lower arm 5. Subjective symptoms Likert scale

Countries

Japan

Contacts

Public ContactNaoko SUZUKI

ORTHOMEDICO Inc. R&D Department

nao@orthomedico.jp03-3818-0610

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026